Carter Worth And Mike Khouw's Bristol-Myers Squibb Options Trade

On CNBC's "Options Action," Carter Worth spoke about price action in Bristol-Myers Squibb Co BMY.

He showed on the chart that Bristol-Myers has been underperforming Health Care SPDR XLV since 2016, but in the last two months it's performing better than the sector. Worth thinks that at minimum, the stock could return to trend and trade higher to $55.

Khouw suggested that investors should buy the Dec. $50 call in Bristol-Myers for $2.50. The trade breaks even at $52.50 or 3.37% above the current stock price.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date of Trade
ticker
Put/Call
Strike Price
DTE
Sentiment
Posted In: OptionsMarketsMediaCarter WorthCNBCMike KhouwOptions Action
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!